- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT00615914
Special Survey on Parkinson's Disease Patients Treated Long-term Use of Pramipexole
10 czerwca 2014 zaktualizowane przez: Boehringer Ingelheim
Pramipexole Special Survey on Long-Term Use
The survey is conducted to collect safety and effectiveness information on the use of Pramipexole for long time of period in daily clinical settings in Japan.
Przegląd badań
Status
Zakończony
Warunki
Typ studiów
Obserwacyjny
Zapisy (Rzeczywisty)
1645
Kontakty i lokalizacje
Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.
Lokalizacje studiów
-
-
-
Agano, Japonia
- Boehringer Ingelheim Investigational Site
-
Aizuwakamatsu, Japonia
- Boehringer Ingelheim Investigational Site
-
Akashi, Japonia
- Boehringer Ingelheim Investigational Site
-
Akita, Japonia
- Boehringer Ingelheim Investigational Site
-
Asahikawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Asakura, Japonia
- Boehringer Ingelheim Investigational Site
-
Ayagawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Azumino, Japonia
- Boehringer Ingelheim Investigational Site
-
Bando, Japonia
- Boehringer Ingelheim Investigational Site
-
Beppu, Japonia
- Boehringer Ingelheim Investigational Site
-
Bihoro, Japonia
- Boehringer Ingelheim Investigational Site
-
Chiba, Japonia
- Boehringer Ingelheim Investigational Site
-
Chikusei, Japonia
- Boehringer Ingelheim Investigational Site
-
Chuo, Japonia
- Boehringer Ingelheim Investigational Site
-
Date, Japonia
- Boehringer Ingelheim Investigational Site
-
Ebetsu, Japonia
- Boehringer Ingelheim Investigational Site
-
Ebina, Japonia
- Boehringer Ingelheim Investigational Site
-
Eiheiji, Japonia
- Boehringer Ingelheim Investigational Site
-
Fuchu, Japonia
- Boehringer Ingelheim Investigational Site
-
Fuji, Japonia
- Boehringer Ingelheim Investigational Site
-
Fujieda, Japonia
- Boehringer Ingelheim Investigational Site
-
Fujinomiya, Japonia
- Boehringer Ingelheim Investigational Site
-
Fujioka, Japonia
- Boehringer Ingelheim Investigational Site
-
Fujisawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Fujiyoshida, Japonia
- Boehringer Ingelheim Investigational Site
-
Fukaya, Japonia
- Boehringer Ingelheim Investigational Site
-
Fukui, Japonia
- Boehringer Ingelheim Investigational Site
-
Fukuoka, Japonia
- Boehringer Ingelheim Investigational Site
-
Fukushima, Japonia
- Boehringer Ingelheim Investigational Site
-
Fukuyama, Japonia
- Boehringer Ingelheim Investigational Site
-
Geisei, Japonia
- Boehringer Ingelheim Investigational Site
-
Gifu, Japonia
- Boehringer Ingelheim Investigational Site
-
Ginowan, Japonia
- Boehringer Ingelheim Investigational Site
-
Hachinohe, Japonia
- Boehringer Ingelheim Investigational Site
-
Hadano, Japonia
- Boehringer Ingelheim Investigational Site
-
Haebaru, Japonia
- Boehringer Ingelheim Investigational Site
-
Hagahama, Japonia
- Boehringer Ingelheim Investigational Site
-
Hakodate, Japonia
- Boehringer Ingelheim Investigational Site
-
Hamada, Japonia
- Boehringer Ingelheim Investigational Site
-
Hamamatsu, Japonia
- Boehringer Ingelheim Investigational Site
-
Hayashima, Japonia
- Boehringer Ingelheim Investigational Site
-
Higashimurayama, Japonia
- Boehringer Ingelheim Investigational Site
-
Higashiosaka, Japonia
- Boehringer Ingelheim Investigational Site
-
Higashiyamato, Japonia
- Boehringer Ingelheim Investigational Site
-
Himeji, Japonia
- Boehringer Ingelheim Investigational Site
-
Hiratsuka, Japonia
- Boehringer Ingelheim Investigational Site
-
Hirokawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Hirosaki, Japonia
- Boehringer Ingelheim Investigational Site
-
Hiroshima, Japonia
- Boehringer Ingelheim Investigational Site
-
Hita, Japonia
- Boehringer Ingelheim Investigational Site
-
Hofu, Japonia
- Boehringer Ingelheim Investigational Site
-
Ibaragi, Japonia
- Boehringer Ingelheim Investigational Site
-
Ichikikushikino, Japonia
- Boehringer Ingelheim Investigational Site
-
Ichinomiya, Japonia
- Boehringer Ingelheim Investigational Site
-
Ichinoseki, Japonia
- Boehringer Ingelheim Investigational Site
-
Iizuka, Japonia
- Boehringer Ingelheim Investigational Site
-
Ikeda, Japonia
- Boehringer Ingelheim Investigational Site
-
Ikoma, Japonia
- Boehringer Ingelheim Investigational Site
-
Ina, Japonia
- Boehringer Ingelheim Investigational Site
-
Inazawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Inba, Japonia
- Boehringer Ingelheim Investigational Site
-
Inuyama, Japonia
- Boehringer Ingelheim Investigational Site
-
Isezaki, Japonia
- Boehringer Ingelheim Investigational Site
-
Itoigawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Iwaki, Japonia
- Boehringer Ingelheim Investigational Site
-
Iwata, Japonia
- Boehringer Ingelheim Investigational Site
-
Joetsu, Japonia
- Boehringer Ingelheim Investigational Site
-
Kagoshima, Japonia
- Boehringer Ingelheim Investigational Site
-
Kahoku, Japonia
- Boehringer Ingelheim Investigational Site
-
Kajiki, Japonia
- Boehringer Ingelheim Investigational Site
-
Kakegawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Kakogawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Kamisu, Japonia
- Boehringer Ingelheim Investigational Site
-
Kamogawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Kanazawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Kannonji, Japonia
- Boehringer Ingelheim Investigational Site
-
Karatsu, Japonia
- Boehringer Ingelheim Investigational Site
-
Kashima, Japonia
- Boehringer Ingelheim Investigational Site
-
Kashiwa, Japonia
- Boehringer Ingelheim Investigational Site
-
Kashiwazaki, Japonia
- Boehringer Ingelheim Investigational Site
-
Kasukabe, Japonia
- Boehringer Ingelheim Investigational Site
-
Kato, Japonia
- Boehringer Ingelheim Investigational Site
-
Kawagoe, Japonia
- Boehringer Ingelheim Investigational Site
-
Kawasaki, Japonia
- Boehringer Ingelheim Investigational Site
-
Kawatana, Japonia
- Boehringer Ingelheim Investigational Site
-
Kikugawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Kirishima, Japonia
- Boehringer Ingelheim Investigational Site
-
Kitakyushu, Japonia
- Boehringer Ingelheim Investigational Site
-
Kiyose, Japonia
- Boehringer Ingelheim Investigational Site
-
Kiyotake, Japonia
- Boehringer Ingelheim Investigational Site
-
Kizugawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Kobayashi, Japonia
- Boehringer Ingelheim Investigational Site
-
Kobe, Japonia
- Boehringer Ingelheim Investigational Site
-
Kochi, Japonia
- Boehringer Ingelheim Investigational Site
-
Kodaira, Japonia
- Boehringer Ingelheim Investigational Site
-
Kofu, Japonia
- Boehringer Ingelheim Investigational Site
-
Koga, Japonia
- Boehringer Ingelheim Investigational Site
-
Kokubunji, Japonia
- Boehringer Ingelheim Investigational Site
-
Komae, Japonia
- Boehringer Ingelheim Investigational Site
-
Komatsu, Japonia
- Boehringer Ingelheim Investigational Site
-
Komoro, Japonia
- Boehringer Ingelheim Investigational Site
-
Koriyama, Japonia
- Boehringer Ingelheim Investigational Site
-
Koshi, Japonia
- Boehringer Ingelheim Investigational Site
-
Koshigawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Kumamoto, Japonia
- Boehringer Ingelheim Investigational Site
-
Kurashiki, Japonia
- Boehringer Ingelheim Investigational Site
-
Kurayoshi, Japonia
- Boehringer Ingelheim Investigational Site
-
Kure, Japonia
- Boehringer Ingelheim Investigational Site
-
Kurume, Japonia
- Boehringer Ingelheim Investigational Site
-
Kushiro, Japonia
- Boehringer Ingelheim Investigational Site
-
Kutchan, Japonia
- Boehringer Ingelheim Investigational Site
-
Kuwana, Japonia
- Boehringer Ingelheim Investigational Site
-
Kyonan, Japonia
- Boehringer Ingelheim Investigational Site
-
Kyoto, Japonia
- Boehringer Ingelheim Investigational Site
-
Maebaru, Japonia
- Boehringer Ingelheim Investigational Site
-
Maebashi, Japonia
- Boehringer Ingelheim Investigational Site
-
Maibara, Japonia
- Boehringer Ingelheim Investigational Site
-
Maizuru, Japonia
- Boehringer Ingelheim Investigational Site
-
Marugame, Japonia
- Boehringer Ingelheim Investigational Site
-
Matsuda, Japonia
- Boehringer Ingelheim Investigational Site
-
Matsudo, Japonia
- Boehringer Ingelheim Investigational Site
-
Matsue, Japonia
- Boehringer Ingelheim Investigational Site
-
Matsumoto, Japonia
- Boehringer Ingelheim Investigational Site
-
Matsuyama, Japonia
- Boehringer Ingelheim Investigational Site
-
Mibu, Japonia
- Boehringer Ingelheim Investigational Site
-
Mihara, Japonia
- Boehringer Ingelheim Investigational Site
-
Miki, Japonia
- Boehringer Ingelheim Investigational Site
-
Minakami, Japonia
- Boehringer Ingelheim Investigational Site
-
Minamata, Japonia
- Boehringer Ingelheim Investigational Site
-
Minobu, Japonia
- Boehringer Ingelheim Investigational Site
-
Misashino, Japonia
- Boehringer Ingelheim Investigational Site
-
Mito, Japonia
- Boehringer Ingelheim Investigational Site
-
Miyaki, Japonia
- Boehringer Ingelheim Investigational Site
-
Miyakonojo, Japonia
- Boehringer Ingelheim Investigational Site
-
Miyazaki, Japonia
- Boehringer Ingelheim Investigational Site
-
Mooka, Japonia
- Boehringer Ingelheim Investigational Site
-
Moriguchi, Japonia
- Boehringer Ingelheim Investigational Site
-
Morioka, Japonia
- Boehringer Ingelheim Investigational Site
-
Moriya, Japonia
- Boehringer Ingelheim Investigational Site
-
Moriyama, Japonia
- Boehringer Ingelheim Investigational Site
-
Muroran, Japonia
- Boehringer Ingelheim Investigational Site
-
Nagakute, Japonia
- Boehringer Ingelheim Investigational Site
-
Nagaoka, Japonia
- Boehringer Ingelheim Investigational Site
-
Nagaokakyo, Japonia
- Boehringer Ingelheim Investigational Site
-
Nagasaki, Japonia
- Boehringer Ingelheim Investigational Site
-
Nagoya, Japonia
- Boehringer Ingelheim Investigational Site
-
Nangoku, Japonia
- Boehringer Ingelheim Investigational Site
-
Nara, Japonia
- Boehringer Ingelheim Investigational Site
-
Narita, Japonia
- Boehringer Ingelheim Investigational Site
-
Naruto, Japonia
- Boehringer Ingelheim Investigational Site
-
Nichinan, Japonia
- Boehringer Ingelheim Investigational Site
-
Niigata, Japonia
- Boehringer Ingelheim Investigational Site
-
Niihama, Japonia
- Boehringer Ingelheim Investigational Site
-
Nikko, Japonia
- Boehringer Ingelheim Investigational Site
-
Nishigo, Japonia
- Boehringer Ingelheim Investigational Site
-
Nishihara, Japonia
- Boehringer Ingelheim Investigational Site
-
Nishinomiya, Japonia
- Boehringer Ingelheim Investigational Site
-
Nishio, Japonia
- Boehringer Ingelheim Investigational Site
-
Nishitokyo, Japonia
- Boehringer Ingelheim Investigational Site
-
Nobeoka, Japonia
- Boehringer Ingelheim Investigational Site
-
Noboribetsu, Japonia
- Boehringer Ingelheim Investigational Site
-
Numazu, Japonia
- Boehringer Ingelheim Investigational Site
-
Obama, Japonia
- Boehringer Ingelheim Investigational Site
-
Obihiro, Japonia
- Boehringer Ingelheim Investigational Site
-
Odate, Japonia
- Boehringer Ingelheim Investigational Site
-
Odawara, Japonia
- Boehringer Ingelheim Investigational Site
-
Ofunato, Japonia
- Boehringer Ingelheim Investigational Site
-
Ogaki, Japonia
- Boehringer Ingelheim Investigational Site
-
Ohzu, Japonia
- Boehringer Ingelheim Investigational Site
-
Oiso, Japonia
- Boehringer Ingelheim Investigational Site
-
Oita, Japonia
- Boehringer Ingelheim Investigational Site
-
Ojiya, Japonia
- Boehringer Ingelheim Investigational Site
-
Okawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Okayama, Japonia
- Boehringer Ingelheim Investigational Site
-
Omaezaki, Japonia
- Boehringer Ingelheim Investigational Site
-
Omura, Japonia
- Boehringer Ingelheim Investigational Site
-
Omuta, Japonia
- Boehringer Ingelheim Investigational Site
-
Onga, Japonia
- Boehringer Ingelheim Investigational Site
-
Onojo, Japonia
- Boehringer Ingelheim Investigational Site
-
Onomichi, Japonia
- Boehringer Ingelheim Investigational Site
-
Osaka, Japonia
- Boehringer Ingelheim Investigational Site
-
Otsu, Japonia
- Boehringer Ingelheim Investigational Site
-
Ozu, Japonia
- Boehringer Ingelheim Investigational Site
-
Sado, Japonia
- Boehringer Ingelheim Investigational Site
-
Saga, Japonia
- Boehringer Ingelheim Investigational Site
-
Sagamihara, Japonia
- Boehringer Ingelheim Investigational Site
-
Saitama, Japonia
- Boehringer Ingelheim Investigational Site
-
Sakai, Japonia
- Boehringer Ingelheim Investigational Site
-
Sakaide, Japonia
- Boehringer Ingelheim Investigational Site
-
Sakata, Japonia
- Boehringer Ingelheim Investigational Site
-
Saku, Japonia
- Boehringer Ingelheim Investigational Site
-
Sanjo, Japonia
- Boehringer Ingelheim Investigational Site
-
Sano, Japonia
- Boehringer Ingelheim Investigational Site
-
Sanyoonoda, Japonia
- Boehringer Ingelheim Investigational Site
-
Sapporo, Japonia
- Boehringer Ingelheim Investigational Site
-
Sasebo, Japonia
- Boehringer Ingelheim Investigational Site
-
Seijo, Japonia
- Boehringer Ingelheim Investigational Site
-
Sendai, Japonia
- Boehringer Ingelheim Investigational Site
-
Shimabara, Japonia
- Boehringer Ingelheim Investigational Site
-
Shimonoseki, Japonia
- Boehringer Ingelheim Investigational Site
-
Shimotsuke, Japonia
- Boehringer Ingelheim Investigational Site
-
Shingu, Japonia
- Boehringer Ingelheim Investigational Site
-
Shinshiro, Japonia
- Boehringer Ingelheim Investigational Site
-
Shizuoka, Japonia
- Boehringer Ingelheim Investigational Site
-
Shunan, Japonia
- Boehringer Ingelheim Investigational Site
-
Soo, Japonia
- Boehringer Ingelheim Investigational Site
-
Suita, Japonia
- Boehringer Ingelheim Investigational Site
-
Tajimi, Japonia
- Boehringer Ingelheim Investigational Site
-
Takamatsu, Japonia
- Boehringer Ingelheim Investigational Site
-
Takanabe, Japonia
- Boehringer Ingelheim Investigational Site
-
Takaoka, Japonia
- Boehringer Ingelheim Investigational Site
-
Takasago, Japonia
- Boehringer Ingelheim Investigational Site
-
Takasaki, Japonia
- Boehringer Ingelheim Investigational Site
-
Takatsuki, Japonia
- Boehringer Ingelheim Investigational Site
-
Takehara, Japonia
- Boehringer Ingelheim Investigational Site
-
Toda, Japonia
- Boehringer Ingelheim Investigational Site
-
Togitsu, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokoname, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokushima, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Adachi-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Bunkyo-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Chiyoda-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Edogawa-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Itabashi-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Katsushika-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Kita-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Meguro-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Minayo-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Nakano-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Nerima-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Ota-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Setagaya-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Shinagawa-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Shinjuku-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Suginami-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tokyo Toshima-ku, Japonia
- Boehringer Ingelheim Investigational Site
-
Tomakomai, Japonia
- Boehringer Ingelheim Investigational Site
-
Tomiai, Japonia
- Boehringer Ingelheim Investigational Site
-
Tondabayashi, Japonia
- Boehringer Ingelheim Investigational Site
-
Toon, Japonia
- Boehringer Ingelheim Investigational Site
-
Toride, Japonia
- Boehringer Ingelheim Investigational Site
-
Toyama, Japonia
- Boehringer Ingelheim Investigational Site
-
Toyoake, Japonia
- Boehringer Ingelheim Investigational Site
-
Toyokawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Toyonaka, Japonia
- Boehringer Ingelheim Investigational Site
-
Toyooka, Japonia
- Boehringer Ingelheim Investigational Site
-
Tsu, Japonia
- Boehringer Ingelheim Investigational Site
-
Tsubata, Japonia
- Boehringer Ingelheim Investigational Site
-
Tsuchiura, Japonia
- Boehringer Ingelheim Investigational Site
-
Tsukuba, Japonia
- Boehringer Ingelheim Investigational Site
-
Tsuruoka, Japonia
- Boehringer Ingelheim Investigational Site
-
Uchinada, Japonia
- Boehringer Ingelheim Investigational Site
-
Ueda, Japonia
- Boehringer Ingelheim Investigational Site
-
Uji, Japonia
- Boehringer Ingelheim Investigational Site
-
Ujo, Japonia
- Boehringer Ingelheim Investigational Site
-
Urayasu, Japonia
- Boehringer Ingelheim Investigational Site
-
Uruma, Japonia
- Boehringer Ingelheim Investigational Site
-
Utsunomiya, Japonia
- Boehringer Ingelheim Investigational Site
-
Wakayama, Japonia
- Boehringer Ingelheim Investigational Site
-
Yamagata, Japonia
- Boehringer Ingelheim Investigational Site
-
Yamaguchi, Japonia
- Boehringer Ingelheim Investigational Site
-
Yamamoto, Japonia
- Boehringer Ingelheim Investigational Site
-
Yanai, Japonia
- Boehringer Ingelheim Investigational Site
-
Yao, Japonia
- Boehringer Ingelheim Investigational Site
-
Yashiro, Japonia
- Boehringer Ingelheim Investigational Site
-
Yazu, Japonia
- Boehringer Ingelheim Investigational Site
-
Yokkaichi, Japonia
- Boehringer Ingelheim Investigational Site
-
Yokohama, Japonia
- Boehringer Ingelheim Investigational Site
-
Yokote, Japonia
- Boehringer Ingelheim Investigational Site
-
Yoro, Japonia
- Boehringer Ingelheim Investigational Site
-
Yoshinogawa, Japonia
- Boehringer Ingelheim Investigational Site
-
Yufu, Japonia
- Boehringer Ingelheim Investigational Site
-
Zama, Japonia
- Boehringer Ingelheim Investigational Site
-
-
Kryteria uczestnictwa
Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.
Kryteria kwalifikacji
Wiek uprawniający do nauki
- Dziecko
- Dorosły
- Starszy dorosły
Akceptuje zdrowych ochotników
Nie
Płeć kwalifikująca się do nauki
Wszystko
Metoda próbkowania
Próbka bez prawdopodobieństwa
Badana populacja
Parkinson's disease patients in daily clinical settings
Opis
Inclusion Criteria:
Patients with Parkinson's disease
Exclusion Criteria:
Patients should have been treated according to the Japanese insert slip
Plan studiów
Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.
Jak projektuje się badanie?
Szczegóły projektu
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Proportion of Adverse Events, Adverse Drug Reactions, Serious Adverse Events
Ramy czasowe: during 18 months
|
The aim of this Post Marketing Surveillance (PMS) was to obtain long-term safety data with treatment of pramipexole in Parkinson's disease (PD) patients.
Therefore these items were considered as a safety evaluation.
|
during 18 months
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Clinical Global Impression of Improvement
Ramy czasowe: 18 months
|
Investigators evaluation of the PD symptoms on a rating scale of 5 categories (very much improved, much improved, minimally improved, no effect, and unassessable).
|
18 months
|
Change From Baseline in Unified Parkinson's Disease Rating Scale (UPDRS) Part III Total Score
Ramy czasowe: Baseline and at 18 months (or at the time of discontinuation)
|
Motor examination is assessed by 27 questionnaire items in UPDRS Part III section.
Each item is scored from 0 (best) to 4 (worst), and the total score of UPDRS Part III is from 0 (best) to 108 (worst).
A decrease in the score means improvement.
|
Baseline and at 18 months (or at the time of discontinuation)
|
Change From Baseline in Modified Hoehn & Yahr Rating Scale
Ramy czasowe: Baseline and at 18 months (or at the time of discontinuation)
|
A severity of PD symptom are assessed by Modified Hoehn & Yahr rating scale.
This scale consist of 10 levels including additional evaluation levels defined in Japan.
Ten levels are described by 0 (best), 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5, 5 (worst).
|
Baseline and at 18 months (or at the time of discontinuation)
|
Współpracownicy i badacze
Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.
Sponsor
Publikacje i pomocne linki
Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.
Przydatne linki
Daty zapisu na studia
Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.
Główne daty studiów
Rozpoczęcie studiów
1 lutego 2004
Zakończenie podstawowe (Rzeczywisty)
1 marca 2009
Daty rejestracji na studia
Pierwszy przesłany
31 stycznia 2008
Pierwszy przesłany, który spełnia kryteria kontroli jakości
13 lutego 2008
Pierwszy wysłany (Oszacować)
14 lutego 2008
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
11 lipca 2014
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
10 czerwca 2014
Ostatnia weryfikacja
1 czerwca 2014
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 248.547
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Choroba Parkinsona
-
Bambino Gesù Hospital and Research InstituteZakończonyCiężka otyłość dziecięca (BMI > 97° szt. -według wykresów BMI Centers for Disease Control and Prevention-) | Zmienione testy czynnościowe wątroby | Nietolerancja glikemicznaWłochy
-
Spero TherapeuticsZakończonyKompleks Mycobacterium Avium | Niegruźlicze Mycobacterium Pulmonary DiseaseStany Zjednoczone
-
Janssen Pharmaceutical K.K.RekrutacyjnyOporna na leczenie Mycobacterium Avium Complex-lung Disease (MAC-LD)Tajwan, Republika Korei, Japonia
-
Adelphi Values LLCBlueprint Medicines CorporationZakończonyBiałaczka z komórek tucznych (MCL) | Agresywna mastocytoza układowa (ASM) | SM w Assoc Clonal Hema Lineage Non-mast Cell Lineage Disease (SM-AHNMD) | Tląca się mastocytoza układowa (SSM) | Indolentna układowa mastocytoza (ISM) Podgrupa ISM w pełni zatrudnionaStany Zjednoczone